Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry;
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Gabani R.
- Brugaletta S.
- Bujak K.
- Pèrez-Vizcayno M.J.
- Jiménez-Quevedo P.
- Arévalos V.
- Muñoz-García E.
- Trillo-Nouche R.
- del Valle R.
- de la Torre Hernández J.M.
- Salido L.
- Gutiérrez E.
- Pan M.
- Sánchez-Gila J.
- García del Blanco B.
- Moreno R.
- Blanco Mata R.
- Oteo J.F.
- Amat-Santos I.
- Regueiro A.
- Nogales J.M.
- Fernández-Nofrerías E.
- Andraka L.
- Ferrer M.C.
- Pinar E.
- Romaguera R.
- Cuellas Ramón C.
- Alfonso F.
- García-Blas S.
- Piñero A.
- Ignasi J.
- Díaz Mèndez R.
- Bordes P.
- Meseguer J.
- Nombela-Franco L.
- Sabaté M.
Grupos
Abstract
Introduction and objectives: Impact of gender on long-term outcomes after transcatheter aortic valve implantation (TAVI) remains uncertain. We aimed to investigate gender-specific differences in TAVI and its impact on outcomes. Methods: This analysis used data from the prospective Spanish TAVI registry, which included consecutive TAVI patients treated in 46 Spanish centers from 2009 to 2021. The primary endpoint was all-cause mortality at 12 months. Secondary endpoints included in-hospital and 30-day mortality and TAVI-related complications. Adjusted logistic and Cox regression analyses were performed. Results: The study included 12 253 consecutive TAVI patients with a mean age of 81.2 ± 6.4 years. Women (53.9%) were older, and had a higher STS-PROM score (7.0 ± 7.0 vs 6.2 ± 6.7; P < .001) than men. Overall, the TAVI-related complication rate was similar between women and men, with specific gender-related complications. While women more frequently developed in-hospital vascular complications (13.6% vs 9.8%; P < .001) and cardiac tamponade (1.5% vs 0.6%; P = .009), men showed a higher incidence of permanent pacemaker implantation (14.5% vs 17.4%; P = .009). There was no difference in all-cause mortality either in hospital (3.6% vs 3.6%, adjusted OR, 1.01; 95%CI, 0.83-1.23; P = .902), at 30 days (4.2% vs 4.2%, adjusted OR, 0.90; 95%CI, 0.65-1.25; P = .564) or at 1 year (11% vs 13%, adjusted HR, 0.94; 95%CI, 0.80-1.11; P = .60). Conclusions: Women treated with TAVI are older and have more comorbidities than men, leading to distinct complications between genders. Nevertheless, all-cause mortality in the short-term and at 1-year was similar between men and women. © 2024 Sociedad Española de Cardiología
Datos de la publicación
- ISSN/ISSNe:
- 0300-8932, 1579-2242
- Tipo:
- Article
- Páginas:
- 338-346
- PubMed:
- 39187234
- Enlace a otro recurso:
- www.scopus.com
- Factor de Impacto:
- 0,407 SCImago ℠
- Cuartil:
- Q3 SCImago ℠
REVISTA ESPANOLA DE CARDIOLOGIA EDICIONES DOYMA S A
Documentos
- No hay documentos
Filiaciones
Keywords
- Aged; Aged, 80 and over; Aortic Valve Stenosis; Female; Follow-Up Studies; Hospital Mortality; Humans; Male; Postoperative Complications; Prospective Studies; Registries; Risk Factors; Sex Factors; Spain; Survival Rate; Time Factors; Transcatheter Aortic Valve Replacement; Treatment Outcome; aged; all cause mortality; Article; clinical outcome; comorbidity; controlled study; female; heart tamponade; human; major clinical study; male; mortality rate; sex difference; transcatheter aortic valve implantation; very elderly; aortic valve stenosis; clinical trial; epidemiology; follow up; hospital mortality; multicenter study; postoperative complication; procedures; prospective study; register; risk factor; sex factor; Spain; surgery; survival rate; time factor; treatment outcome
Campos de Estudio
Cita
Gabani R,Brugaletta S,Bujak K,Pèrez MJ,Jiménez P,Arévalos V,Muñoz E,Trillo R,del Valle R,de la Torre JM,Salido L,Gutiérrez E,Pan M,Sánchez J,García del Blanco B,Moreno R,Blanco R,Oteo JF,Amat I,Regueiro A,TEN F,Nogales JM,Fernández E,Andraka L,Ferrer MC,Pinar E,Romaguera R,Cuellas C,Alfonso F,García S,Piñero A,Ignasi J,Díaz R,Bordes P,Meseguer J,Nombela L,Sabaté M. Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry;. Rev. Esp. Cardiol. 2025. 78. (4):p. 338-346. IF:7,200. (1).
Portal de investigación